Evolutionary concepts in biobanking - the BC BioLibrary

[1]  S. Niemeyer,et al.  Informed consent in biobank research: a deliberative approach to the debate. , 2009, Social science & medicine.

[2]  Mitch Dowsett,et al.  Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer , 2008, Clinical Cancer Research.

[3]  Rebecca O Barnes,et al.  Influence of Evolution in Tumor Biobanking on the Interpretation of Translational Research , 2008, Cancer Epidemiology Biomarkers & Prevention.

[4]  K. Brazil,et al.  Who's minding the shop? The role of Canadian research ethics boards in the creation and uses of registries and biobanks , 2008, BMC medical ethics.

[5]  E. de Álava,et al.  Biobanking: old activity or young discipline? , 2008, Seminars in diagnostic pathology.

[6]  D. Secko,et al.  Perspectives on Engaging the Public in the Ethics of Emerging Biotechnologies: From Salmon to Biobanks to Neuroethics , 2008, Accountability in research.

[7]  Fay Betsou,et al.  Biobanking for better healthcare , 2008, Molecular oncology.

[8]  R. Dhir.  Prostate cancer biobanking , 2008, Current opinion in urology.

[9]  Rajiv Dhir,et al.  The development and deployment of Common Data Elements for tissue banks for translational research in cancer – An emerging standard based approach for the Mesothelioma Virtual Tissue Bank , 2008, BMC Cancer.

[10]  Geoffrey S Ginsburg,et al.  Centralized biorepositories for genetic and genomic research. , 2008, JAMA.

[11]  P. Riegman,et al.  Biobanking for Interdisciplinary Clinical Research , 2007, Pathobiology.

[12]  Eric J Topol,et al.  The genomics gold rush. , 2007, JAMA.

[13]  H. Busby.  Biobanks, bioethics and concepts of donated blood in the UK. , 2006, Sociology of health & illness.

[14]  Johane Patenaude,et al.  A biobank management model applicable to biomedical research , 2006, BMC medical ethics.

[15]  R. Strausberg,et al.  Oncogenomics and the development of new cancer therapies , 2004, Nature.

[16]  Brenda Eskenazi,et al.  Biological sample collection and processing for molecular epidemiological studies. , 2003, Mutation research.

[17]  P. Catalano,et al.  High rate of consent to bank biologic samples for future research: the Eastern Cooperative Oncology Group experience. , 2002, Journal of the National Cancer Institute.

[18]  J. Towbin,et al.  The failing heart , 2002, Nature.

[19]  D. Hall.  Reflecting on Redfern: What can we learn from the Alder Hey story? , 2001, Archives of disease in childhood.

[20]  Mike Clarke,et al.  Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[21]  Mike Clarke,et al.  Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[22]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[23]  M. Day,et al.  Key Issues , 1981, Philosophy.

[24]  Canadian tumour repository network. , 2010, Biopreservation and biobanking.

[25]  R. Dhir,et al.  Timing of consent for the research use of surgically removed tissue , 2009, Cancer.

[26]  D. Troyer,et al.  Biorepository standards and protocols for collecting, processing, and storing human tissues. , 2008, Methods in molecular biology.